top of page
Search

Part 4 — Side by Side: What the Evidence Actually Supports

  • Writer: Jesse Christianson
    Jesse Christianson
  • 2 days ago
  • 2 min read

A research-grounded comparison of where THC and CBN stand in the sleep science literature

Sleep Outcome

THC

CBN

Sleep onset latency


(falling asleep faster)

Supported Acute THC consistently associated with faster sleep onset in short-term use across multiple studies

Limited No direct sleep latency data from controlled human trials to date

Sleep maintenance


(staying asleep, nighttime awakenings)

Mixed Acute: modest benefit. Chronic: tolerance develops, WASO increases in long-term users

Emerging Bonn-Miller 2024 RCT shows reduced nighttime awakenings vs. placebo — strongest CBN signal to date

REM sleep effects

Suppresses Strong, consistent evidence of REM reduction and REM latency extension — beneficial for PTSD nightmares, potentially problematic for others

Unknown No human polysomnography data yet — CUPID trial (Woolcock Institute) will address this

Slow-wave (deep) sleep

Increases Acute THC associated with greater time in deep NREM sleep — this may partially offset REM suppression concerns

Unknown Awaiting PSG data from active trials

Psychoactivity

High CB1 agonism produces intoxication at therapeutic doses — barrier for some patients; preference for others

Minimal No reliable psychoactive effect reported in human trials up to 300 mg

Tolerance development

Well-documented Sleep benefits diminish with regular nightly use; withdrawal causes rebound insomnia

Unknown No long-term tolerance data in humans yet

Human clinical trial evidence

Moderate Multiple RCTs and PSG studies across insomnia, PTSD, and pain populations

Early Two significant RCTs (subjective measures) + one PSG trial in progress

Nighttime comfort / wind-down

Supported Consistent self-report and observational data supporting bedtime relaxation

Emerging TruCBN trial showed stress reduction secondary finding at 100 mg

Patient population fit

PTSD sleep disturbance, nightmare disorder, pain-related insomnia, sleep onset difficulty

Sleep maintenance complaints, patients who want non-psychoactive option, nighttime awakening issues

Over the next few days, we’ll begin digging deeper into the terpene profiles themselves:🌿 β-myrcene🌿 linalool🌿 β-caryophyllene

…and why they were intentionally selected in our formulations.

Because the real question was never simply:“THC or CBN?”

It was always:“What is the whole formulation doing together?”

 
 
 

Comments


The Dr. Murse | CannabisDNP primary logo features an Enso—an intentionally imperfect, encompassing circle.
  • Linkedin
  • Facebook
  • Instagram

© 2026 Dr. Murse / CannabisDNP
For adult use only (21+)

608.575.2496
cannabis.dnp@gmail.com

2730 Coolidge Street, Madison, WI 53704

Secure checkout accepted with PayPal, Venmo, and major debit/credit cards

 

139-1393055_we-accept-all-major-credit-and-debit-cards-visa-mastercard-american-express.pn

Important Disclaimers: ​These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any diseases. Although side effects at the recommended dose are generally minimal, it is important to acknowledge them. Commonly reported side effects include dizziness, fatigue, dry mouth, lightheadedness, drowsiness, and nausea. Individual responses to this product may vary, as each person’s physiology is unique. Some individuals may require a higher or lower dose to achieve the desired effect, and outcomes can differ from what is typically expected.

 

© 2035 by Virtu. Powered and secured by Wix

bottom of page